Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group. Mehanna H, et al. Among authors: mistry p. Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449623 Free PMC article. Clinical Trial.
Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.
Jones DA, Mistry P, Dalby M, Fulton-Lieuw T, Kong AH, Dunn J, Mehanna HM, Gray AM. Jones DA, et al. Among authors: mistry p. Eur J Cancer. 2020 Jan;124:178-185. doi: 10.1016/j.ejca.2019.10.025. Epub 2019 Nov 30. Eur J Cancer. 2020. PMID: 31794928 Free PMC article. Clinical Trial.
Development and validation of an improved classification and risk stratification system for carotid body tumors: Multinational collaborative cohort study.
Mehanna H, Mistry P, Golusinski P, Di Maio P, Nankivell P, Snider F, Ferrante AMR, Montalto N, Nicolai P, Marcantoni A, Grandi C, Zavatta M, Grego F, Malec K, Hosal S, Suslu N, Kuscu O, Torrealba I, Valdes F, Sharma N, Ayuk J, Monksfield P, Irving R, Dunn JA, Kay M, Borsetto D. Mehanna H, et al. Among authors: mistry p. Head Neck. 2021 Nov;43(11):3448-3458. doi: 10.1002/hed.26844. Epub 2021 Aug 21. Head Neck. 2021. PMID: 34418219
Management of hot flushes in UK breast cancer patients: clinician and patient perspectives.
Fenlon D, Morgan A, Khambaita P, Mistry P, Dunn J, Ah-See ML, Pennery E, Hunter MS; NCRI CSG Breast Cancer Symptom Working Party. Fenlon D, et al. Among authors: mistry p. J Psychosom Obstet Gynaecol. 2017 Dec;38(4):276-283. doi: 10.1080/0167482X.2017.1350163. Epub 2017 Aug 1. J Psychosom Obstet Gynaecol. 2017. PMID: 28762873 Free article.
Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.
Bruce J, Mazuquin B, Canaway A, Hossain A, Williamson E, Mistry P, Lall R, Petrou S, Lamb SE, Rees S, Padfield E, Vidya R, Thompson AM; Prevention of Shoulder Problems Trial (PROSPER) Study Group. Bruce J, et al. Among authors: mistry p. BMJ. 2021 Nov 10;375:e066542. doi: 10.1136/bmj-2021-066542. BMJ. 2021. PMID: 34759002 Free PMC article. Clinical Trial.
Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
Bruce J, Mazuquin B, Mistry P, Rees S, Canaway A, Hossain A, Williamson E, Padfield EJ, Lall R, Richmond H, Chowdhury L, Lait C, Petrou S, Booth K, Lamb SE, Vidya R, Thompson AM. Bruce J, et al. Among authors: mistry p. Health Technol Assess. 2022 Feb;26(15):1-124. doi: 10.3310/JKNZ2003. Health Technol Assess. 2022. PMID: 35220995 Free article. Clinical Trial.
451 results